Lipidomics is a newly emerged discipline that studies cellular lipids on a large scale based on analytical chemistry principles and technological tools, particularly mass spectrometry. Recently, techniques have greatly advanced and novel applications of lipidomics in the biomedical sciences have emerged. This review provides a timely update on these aspects. After briefly introducing the lipidomics discipline, we compare mass spectrometry-based techniques for analysis of lipids and summarize very recent applications of lipidomics in health and disease. Finally, we discuss the status of the field, future directions, and advantages and limitations of the field.
in 2003 and has greatly advanced in recent years, largely due to the development of mass spectrometry (MS) [4, 5] .
Although a variety of reviews on lipidomics have been published recently [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] , these have had different focuses. The rapid advances in techniques and their applications make the timely reviewing of these aspects necessary. Here, we first review MS-based techniques for the analysis of lipids. These techniques are different in the absence or presence of liquid chromatography (LC) prior to mass spectrometric analysis. They can also be different in their analytical coverage (e.g., "targeted" vs "global" analysis). After comparing techniques, we discuss the applications of lipidomics for a variety of disease states, which have appeared in the last couple of years. Finally, we address how the current studies lead us to the accomplishments for tomorrow in the last section.
1.
Modified Bligh & Dyer method: Chloroform/methanol/H 2 O (1:1:0.9, v/v/v) for extraction of a small amount of biological sample (e.g., < 50 mg of tissue). After phase separation, total lipids are present in the chloroform phase. This is a well-established standard method and broadly practiced. The disadvantages include the use of hazardous chloroform and the collection of chloroform extract from the bottom layer (which may cause the carry-over of water soluble impurities and difficulty in automation).
A soft ionization technique used in mass spectrometry that uses an electrospray produced by applying a strong electric field to a liquid passing through a capillary tube to create a fine aerosol from which ions are formed by desolvation.
Matrix-assisted laser desorption/ionization (MALDI)
A soft ionization technique used in mass spectrometry that allows the analysis of large and/or labile molecules (e.g., peptides, proteins, lipids, and polymers) and is particularly useful for MS imaging of tissue or cell samples. This technique involves embedding analytes in a matrix that absorbs energy at the wavelength of the laser. The pulsed laser irradiates the analytes, triggering ablation and desorption of the analytes and matrix material to facilitate the ionization of the analyte molecules in the hot plume of ablated gases.
Atmospheric pressure chemical ionization (APCI)
A soft ionization technique that utilizes gas-phase ion-molecule reactions at atmospheric pressure. Ionization occurs along a corona discharge electrode where the relative proton affinities of the reactant gas ions (e.g., evaporated mobile phase or solvent in most cases) and the gaseous analyte molecules allow either proton transfer/abstraction or adduct formation to produce the molecular ions.
Atmospheric pressure photoionization (APPI)
A useful alternative ionization technique for analysis of compounds that ionize poorly by ESI and APCI. This technique uses a vacuum-ultraviolet lamp designed for photoionization detection in gas chromatography as a source of 10-eV photons. The mixture of samples and solvent, after fully evaporated, is introduced into the photoionization region where the dopant photoions react to completion with solvent and analyte molecules because the ion source is at atmospheric pressure and the collision rate is high.
Secondary ion mass spectrometry (SIMS) employing silver or gold ions as primary ions
The most sensitive surface analytical technique that is used to analyze the composition of solid surfaces or thin films by bombarding the surface with a focused primary ion beam (e.g., silver, or gold ions) and collecting the ejected secondary ions that are introduced to a mass spectrometer for analysis.
Desorption ESI (DESI)
An ambient ionization technique that is a combination of ESI and desorption ionization methods. Ionization occurs by pneumatically directing a charged electrospray mist to the sample surface where subsequent splashed droplets carry desorbed, ionized analytes that then travel into the atmospheric pressure interface of the mass spectrometer.
Following the ionization of lipids, the ion mobility technique can be applied as an option for an additional dimension of ion manipulation and separation prior to MS analysis [34] . Next, either Full MS or MS/MS analysis (see Box 3 for MS/MS techniques) or both can be performed depending on whether a targeted or global analysis is desired. The MS analysis can be done using either low/unit mass resolution or high mass accuracy/mass resolution instruments [35] . It should be recognized that the mass resolution higher than 75,000 around m/z 800 appears required to avoid potential overlaps between lipid species and other complications [36] . Following MS analysis, data are displayed as MS spectra, MS/MS spectra, ion chromatogram (including total ion chromatogram (TIC) or extracted ion chromatogram (XIC); LC-based approaches only), or images (MS imaging only).
Box 3
Commonly used tandem mass spectrometric techniques in lipidomics
Product ion scan
A tandem mass spectrometric technique where the first mass analyzer selects a specific precursor ion while the second mass analyzer detects all the resultant fragment ions from fragmentation of the selected precursor.
Precursor ion scan (PIS)
A tandem mass spectrometric technique where the first mass analyzer scans all the precursor ions while the second mass analyzer monitors only the selected fragment ion. The selected fragment ion corresponds to a common fragment ion of the precursors; therefore, all the precursors that produce the specified fragment ion during fragmentation are monitored.
Neutral loss scan (NLS)
A tandem mass spectrometric technique where the first mass analyzer scans all the precursor ions while the second mass analyzer scans the fragment ions set at an offset from the first mass analyzer. This offset corresponds to a common neutral loss from the precursor ions; therefore, all the precursors that undergo the loss of the specified neutral fragment are monitored.
Selected/multiple reaction monitoring (SRM/MRM)
A non-scanning tandem mass spectrometric technique used in targeted analysis that performs on triple quadrupole-like instruments and uses two mass analyzers as static mass filters to monitor a particular fragment ion of a selected precursor ion. The specific pair of m/z values associated with the precursor and fragment ions selected is referred to as a "transition". Multiple reaction monitoring (MRM) is used to indicate the parallel acquisition of multiple SRM transitions.
After data acquisition, spectral data are processed for mandatory deisotoping (for correction of the effects of the presence of isotopic clusters on monoisotopic peak intensities) unless the presence of an internal standard and calibration curve for individual species in the case of LC-based lipidomics, followed by identification and quantification of individual lipid species based on the analytical approaches (i.e., shotgun, LC-MS, or imaging). Those qualitative and quantitative lipid data are further processed by bioinformatic data mining [37] to explore underlying mechanisms of lipid metabolism and its (dys)regulation in health vs. disease, leading to applications in the biomedical sciences (see below), including the discovery of biomarkers or drug targets for diseases as well as guidance in precision/ personalized medicine and dietary intervention.
Techniques
As shown in Figure 1 , lipids can be analyzed either directly from the biological materials (i.e., MS imaging) or after being extracted with organic solvents. For the latter, there are two categories of MS-based approaches: shotgun or LC-based lipidomics. These approaches are summarized in Table 1 . The following is a brief comparison of the distinct and common features of shotgun and LC-based approaches.
Biological lipid extracts are typically complex, including the diversity in lipid classes/ subclasses/molecular species and the vast dynamic range in the endogenous contents of individual species. Therefore, reduction of the complexity of lipid extracts is essential for reliable and accurate identification and quantification of individual species in the complex extract. LC-based lipidomics achieves this utilizing separation science in addition to enriching the low abundance species [33, 38] . In contrast, shotgun lipidomics is a highthroughput approach but at expense of preserving the complexity of a lipid extract because of the absence of pre-chromatographic separation. In the practice of shotgun lipidomics, the complexity has been strategically reduced either during sample preparation as aforementioned or during MS analysis via intrasource separation/selective ionization or both [4, 11] . In addition, monitoring head-group related fragments that are characteristic to a specific lipid class by MS/MS (Box 3) selectively detects molecular species within the class without interference from other coexisting classes.
In addition to the difference in reducing the complexity of lipid extract, shotgun and LCbased lipidomics are also different in their data output and, subsequently, the requisite data analysis. The data acquired in shotgun platforms are solely mass spectra including full MS and MS/MS spectra. Shotgun lipidomics identifies lipid species using either product ion spectra or building block-related NLS/PIS spectra. Since identification of a large number of lipid species requires the acquisition of numerous product ion spectra but a significantly smaller number of building block-related NLS/PIS spectra, the latter is much more efficient. The data outputted from LC-MS platforms include both chromatograms (e.g., TIC or XIC) and mass spectra (e.g., full MS and MS/MS spectra including product ion and SRM/MRM data). LC-MS lipidomics identify lipid species from both chromatogram (i.e., retention time) and mass spectral data (e.g., product ion spectra of selected precursor ions, or SRM/MRM from pre-knowledge of targeted precursors). Retention time adds a valuable feature to the species identification in LC-MS approaches. However, the time restriction originating from the "on-the-fly" chromatographic analysis markedly limits the number of the selected precursor ions that can be fragmented during a single LC run. In contrast, all precursor ions of interest are subjected to numerous MS/MS scans, beneficial from the "unlimited" time in shotgun lipidomics. Although shotgun and LC-MS lipidomics approaches are different in multiple aspects, they share common features too. One of the common features is that ESI-and MALDI-MS are both applicable to these approaches although LC-MALDI-MS is operated off-line and not as commonly used as LC-ESI-MS. Another common feature is that shotgun and LC-MS approaches are both compatible to ion mobility MS [34] which adds an additional dimension of separation. The third feature is that after data acquisition and processing for species identification and quantification, same bioinformatics tools can be applied to the data from both platforms [37, 40] .
Applications of Lipidomics for the Biomedical Sciences Metabolic syndrome
Metabolic syndrome is a serious health condition because the risk factors together significantly raise the chances for metabolically related diseases, such as cardiovascular diseases, diabetes, stroke, and non-alcoholic fatty liver disease, compared to any one factor alone. Moreover, metabolic syndrome is becoming more common due to a rise in obesity rates. Lipidomics can play a key role in mechanistic studies, risk prediction, and therapeutic monitoring for metabolic syndrome-related diseases given the tight association of lipids with these diseases [41] . Lipidomics has long been used for diabetes and obesity research and these applications have been extensively reviewed elsewhere ( Table 2 ). Lipidomics of plasma and lipoprotein fractions has provided insights into the complexities of the highdensity lipoprotein (HDL) lipidome, unraveled the controversies surrounding HDL-based therapies to attenuate vascular disease [42, 43] , and identified phospholipids as a major bioactive component of HDL [42, 44] . The application of lipidomics in vascular health research and ischemic heart disease has demonstrated utilities in population profiling, pathogenesis studies, identification of biomarkers, and monitoring of therapeutic responses through the comprehensive and systematic quantitative analysis of multiple lipid classes including oxidized lipids [45] .
Neurological disorders
The brain contains the highest amount of lipids. Naturally, neurological disorders are associated with lipid signaling, metabolism, trafficking, and homeostasis. Lipidomics can be used to investigate these aspects and to develop biomarkers for early diagnosis and prognosis of these disorders. In fact, lipidomics has been employed to study brain complications since its development [46] . Some recent representative studies on neurological diseases are summarized in Table 2 . Previous studies on brain disorders by lipidomics can be found in the cited review articles (Table 2 ).
Cancer
Lipids play many key roles in all of the basic processes essential for tumor development [47] . For example, lipids play roles in cell growth and metabolism, which are essential for rapidly proliferating cancer cells: non-esterified fatty acids are the major building blocks for lipid biosynthesis and remodeling; cholesterol, phospholipids, and sphingolipids represent the major structural components of cellular membranes; and triglycerides serve as the energy storage depot, which, along with acyl CoA and acylcarnitine, are involved in energy metabolism and ATP production. In addition, bioactive lipids, such as lysophospholipids, play important roles in signaling, functioning as second messengers and as hormones in cancer cells to promote cell proliferation, survival, and migration [48] . Similarly, hydrolysis products of phosphatidylinositol and its phosphorylated derivatives are second messengers to activate the PI 3 K/AKT signaling pathway [49] . The significance of this pathway in chemotherapy and radiotherapy for human cancers is well recognized [49] . It is not surprising that cancer cells undergo profound changes in lipid metabolism and homeostasis, thus offering new diagnostic and therapeutic opportunities that could be unraveled by lipidomics. Body fluids serve as a source of biomarkers for early diagnosis of cancers, as their lipid profiles reflect the general condition of the whole organism. In addition to identifying biomarkers, qualitative and quantitative assessment of lipids in blood and other body fluids may be also useful in monitoring the efficacy and toxicity of anticancer treatment. Some representative lipidomics studies on cancer research from the past couple of years are tabulated ( Table 2 ).
Eye diseases
Lipidomics has enabled analysis of lipids in vision research and ophthalmology to understand and diagnose eye disease (Table 2) . Human meibomian lipids, after mixing with aqueous tears, form the tear film to protect delicate ocular structures from desiccating. Lipidomics has provided insights into the stability of tear film and biomarkers for diagnosis, prognosis and treatment of ocular surface diseases [50, 51] . Lipidomics has also enabled effective lipid-based therapy to replenish tear film lipids for modulating ocular surface inflammation and disease [52] . In addition, mediator lipidomics that focuses on the analysis of lipid-derived bioactive molecules such as lipid second messengers and lipid regulators has targeted ophthalmological processes. Some recent applications of lipidomics on eye diseases are summarized in Table 2 .
Nutrition
Nutritional lipidomics provides a comprehensive view of lipids in nutrition, but its translation to practice via nutritional interventions is still in its infancy [53] . Lipidomics can be effectively used in nutrition research to understand diet-dependent changes in the structure, composition, and function of cellular lipids. Lipidomics can also be used in nutrition study to assign the functions of lipids as signaling molecules, nutrient sensors, and intermediates of metabolic pathways, and to elucidate the interactions between nutrients and human metabolism (Table 2 ). In addition, lipidomics can evaluate the dietary intake in a more standardized and precise way for monitoring the acute, medium term, and chronic effects of dietary components, and may provide nutritional advice to guarantee lifelong optimized health [54, 55] . Lipidomics has provided insights into the molecular mechanism underlying the health benefits of dietary ω-3 polyunsaturated fatty acids (PUFA) and the regulatory role of ω-3 and -6 fatty acids in the inflammatory response [56, 57] . The wise use of lipidomics should be an essential part of future ω-3 trials [57] .
Drug discovery and screens
Lipidomics provides new insights into pharmaceutical research through implementing lipidomics in drug target discovery, screening, toxicity evaluation, preclinical testing, prediction and monitoring of response, and personalized medicine ( Table 2) . For example, a major interest in de novo lipogenesis inhibitors is their proapoptotic effects on cancerous cells. Lipidomics can be used to screen a large variety of candidate anticancer drugs for those that inhibit de novo lipid synthesis [58] and to identify novel drug efficacy biomarkers [59, 60] .
Multi-omics and personalized medicine
A new direction for omics in the biomedical sciences is the reclassification of diseases from a molecular perspective thus playing a key role in personalized medicine [60] . The complexity in health and disease requires multi-omics with each complementing the information provided by the others to understand the biology of the whole system [61] . The elucidation of the crosstalk among different systems can contribute to the discovery of accurate and robust biomarkers at various disease stages for the development of systems medicine [62] . Novel biomarkers can improve risk stratification and patient selection for better treatment response [15] , allow the development of the next generation of therapeutics, and help in the prediction and monitoring of treatment efficacy and response to therapeutic measures [15, 60, 63, 64] . Among multi-omics (mainly represented by genomics, proteomics and metabolomics), metabolomics (including lipidomics) is the latest addition to the omics family. Distinct from the other omics, metabolomics measures the metabolites that are closely related to the phenotypes and thereby are directly connected with biological conditions and disease states [61, 65] . Integration of multiple omics techniques is moving the biomedical field towards personalized medicine as the ultimate paradigm of responsible clinical practice [66] (Table 2) . Translational bioinformatics plays an essential role in this transition by bridging the gap among different knowledge domains for the translation of the enormous data set collected from multi-omics into the simulation of complex systems and predictive models for achieving predictive, preventive and personalized medicine [60, 62] .
Outcomes and Perspectives

Summary of the state of current knowledge: advantages and limitations
Since the emergence of the lipidomics discipline in 2003, the advancing analytical technologies have greatly driven the field to essentially all biological and biomedical areas ( Table 2 ). These technologies include soft ionization methods and other techniques (e.g., ion mobility) in mass spectrometry, separation science such as ultra-performance LC and nanomaterials, analysis of direct infusion (e.g., shotgun lipidomics and MS imaging), and novel bioinformatic strategies and libraries ( Figure 1 and Table 1 ). Lipidomics has led us to identify new signaling molecules, reveal the underlying mechanisms responsible for patho(physio)logical conditions, discover potential biomarkers for early diagnosis and prognosis of diseases, screen drug targets and/or test drug efficacy, guide nutritional intervention, and achieve personalized medicine. These accomplishments are due to not only technique development, but also to the nature of lipidomics in being able to comprehensively analyze hundreds to thousands of lipid species at its current development [10, 32, 67, 68] and to study lipid metabolism [69] .
Regardless of the tremendous advances made in recent years, a few areas of technological progress are still desirable. First, whether individual lipid species can be accurately quantified with current methods is still under debate [11] . Currently, the identification and quantification of individual signaling lipid species, including chiral isomers for eicosanoids, positional isomers of polyphosphoinositides, phospholipids carrying modified fatty acids, a variety of sphingoids, and numerous intermediate metabolites, are still not fully achievable.
In addition, coverage of the entire cellular lipidome is still in dream. Moreover, bioinformatics for interpreting large sets of lipidomics data is largely limited to the levels of lipid classes for the construction of metabolic pathways and network. Currently, the access to the levels of individual lipid species in pathway mapping remains problematic. Finally, a definitive unraveling of the biochemical mechanisms responsible for a disease state is still rare. Accordingly, great efforts are needed for all of these areas.
The most productive avenues for future research
Lipidomics, at its current stage, has been developed in two directions: either targeted or global analysis. The former is mostly used for studying signal processing, while the latter is very powerful for studying lipid metabolism, molecular mechanisms and biomarker discovery. Derivatization appears to be very useful for the development of targeted approaches for both shotgun and LC-based lipidomics [10] . In global analysis, an increase in the coverage of lipid classes and molecular species is critical. The broader the coverage is, the better the approach allows us to map the entire metabolic pathways of lipid classes/ subclasses and individual species of a system and to better understand the inter-relationship between these classes and species within a metabolic pathway or between the metabolic networks. Luckily, different approaches have already demonstrated their power for "visualizing" and understanding the changes of hundreds to thousands of individual species [3, 40, 67, 68] . However, further increases in the coverage of lipid classes and individual species (particularly for those very low abundance species) using an automated, high throughput manner in any platform remain demanding.
The usefulness and power of bioinformatics for interpreting lipidomics data based on mass spectral simulation or dynamic modeling has already been demonstrated [70, 71] . However, these successes are only in isolated studies on different clustered pathways. Similar modeling or novel approaches for analysis of a more comprehensive network or ideally for the entire cellular lipidome are still warranted. Furthermore, as the technologies for lipidomics advance, interweaving of this discipline with other fields becomes demanding. Integration of lipidomics with other omics strategies could maximize the power of lipidomics for understanding the molecular mechanisms underpinning diseases [72, 73] . Thus, in addition to broadening the coverage of lipid analysis, one of the logical future directions in the field should be to integrate lipidomics data with genetic, transcriptional, and enzyme data to perform metabolic pathway reconstruction and flux analyses. The reconstruction of lipid metabolism pathways require novel strategies for pathway mapping of lipid data at the molecular species levels instead of at lipid class/subclass levels [40] . Given the structural diversity of lipid classes and species, these tasks are challenging and require a combination of novel and existing bioinformatics resources. Studying the dynamic changes of a limited set of lipid classes and/or species via lipidomics, through simple stable isotope labeling, has been well practiced [74, 75] . However, studies on assessing enzymatic activities, lipid turnover kinetics, and the effects of individual enzyme activation on lipid homeostasis in a metabolic pathway and/or network are missing. This type of research apparently requires lipidomics techniques possessing sensitive, high throughput, and broad coverage capabilities. Furthermore, more complex studies on the fluxomics scale are needed to reveal the reaction rates in lipid metabolism. These kinds of studies in lipidomics should enable the comprehensive determination of lipid metabolism at the molecular level and provide a true understanding of the roles of lipids in the biomedical sciences.
Finally, as advanced in the sensitivity of modern MS instrumentation, the lower limit of detection at the concentration of amol/mg protein of tissue or cell, or amol/ml of body fluid has been frequently reported in the literature. This concentration is within the range of that in single cells. Therefore, the interest in single cell lipidomics has been greatly raised at the recent related conferences and workshops. In fact, single cell lipidomics is held back more from the obstacles of sample preparation than MS detection [76] . It can be foreseen that this goal is achievable in the near future.
Glossary
Biomarker a characteristic that is objectively measured and evaluated accurately and reproducibly as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention.
Deisotoping the removal of mass spectral complications due to the presence of isotopic clusters.
Fluxomics metabolic flux analysis that integrates in vivo measurements of metabolic fluxes with stoichiometric network models to allow determining absolute flux through large metabolic networks.
Global analysis of lipids
an untargeted analysis that comprehensively analyzes the entire or partial cellular lipidome and aims at detecting every lipid species present in the sample.
Intrasource separation/selective ionization separation of the distinct lipid classes that occur in the electrospray ion source through electric field-induced selective ionization of molecular species possessing differential charge propensities.
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Ion mobility spectrometry (IMS)
an analytical technique that separates and identifies ionized molecules in the gas phase based on their mobility in a carrier buffer gas. The methods include drift-time, aspiration, differential, and traveling-wave IMS.
Lipid extraction a procedure that separates cellular or fluid lipids from the other constituents but also preserves these lipids for further analyses. Most procedures exploit the high solubility of lipids in organic solvents.
Lipidomics the large-scale study of pathways and networks of cellular lipids in biological systems. Lipidomics research studies the structure and function of the complete set of lipids (the lipidome) in a given cell or organism as well as their interactions with other cellular components.
Liquid chromatography (LC)-based lipidomics
the lipidomics approaches that employ LC to separate the complex lipid classes and/or individual lipid species prior to MS analysis.
Mass spectrometry imaging (MS imaging) an in situ technique used in MS to visualize the spatial distribution of chemical compositions by their molecular masses and/or characteristic fragment ions.
Metabolic syndrome a complication due to a group of risk factors for metabolically related diseases. The factors include a large waistline, a high triglyceride level, a low high-density lipoprotein (HDL) cholesterol level, high blood pressure, and high fasting blood sugar.
Metabolic network the complete set of metabolic processes that determine the biochemical properties of a cell. Analysis of metabolic network identifies the relative activities of its individual branches (metabolic pathways) and provides insights into the molecular mechanisms.
Precision/Personalized medicine providing the right patient with the right drug at the right dose at the right time. More broadly, it may be thought of as the tailoring of medical treatment to the individual characteristics, needs and preferences of a patient during all stages of care, leading to better individual treatment. 
Shotgun lipidomics
Tandem mass spectrometry (tandem MS or MS/MS or MS 2 ) the MS technique that involves fragmentation of precursor ions and monitoring of both precursor ions and resultant product (or fragment) ions (see Box 3 for details).
Targeted analysis of lipids the lipidomics approach that focuses on known lipids, and develops a specific method with a high sensitivity for quantitative analysis of these lipids. 
Outstanding Questions
Can we broaden the analysis coverage of lipid classes and individual molecular species to achieve full coverage of the cellular lipidome?
Although advances in mass spectrometry have dramatically increased analytical sensitivity and specificity, and therefore greatly broadened coverage including of lower abundance species, there is still a long way to go to uncover the entire lipidome of certain organisms. Coverage improvements are needed for both known entities (that are difficult to analyze largely because of their very low abundance, isomer differentiation, and variety of acyl chain modifications) and unknown entities.
Can we construct the entire metabolic network at the level of lipid classes and individual molecular species?
Bioinformatics has shown its use and power in interpreting lipidomics data through simulation, modeling, pathway mapping, and network construction. However, the establishment of the entire metabolic network at the lipid molecular species level is still in its infancy and will require contributions from multidisciplinary scientific fields.
How do lipid dynamics and metabolism translate into in-depth insights into the roles of lipids in the biomedical sciences?
Although the dynamics of lipid classes and molecular species have been studied (e.g., through metabolic flux analysis), an evaluation of lipid turnover kinetics and the effects of enzyme (de)activation after perturbation of lipid homeostasis on metabolic pathways/ networks is still missing. This is largely due to the need for high sensitivity, high throughput, and broad coverage lipidomics techniques, which are still under development.
Can we integrate lipidomics with other omics strategies to maximize understanding of the molecular mechanisms underlying diseases?
Metabolomics (including lipidomics) measures metabolites that are closely related to the phenotypes of pathophysiological conditions. The complexity of human disease requires multi-omics approaches where each omics dataset complements the information provided by the others to elucidate systems-level biology. Given the structural diversity of lipid classes and species, integration of lipidomics with other omics is challenging and demands novel bioinformatics resources.
Trends
'Lipidomics' applies to studying lipid metabolism on a broad scale. Lipidomics may elucidate the biochemical mechanism(s) underlying specific changes in lipid metabolism.
Advances in mass spectrometry have greatly accelerated the lipidomics field. Chemical derivatization has shown its broad use in improving analytical sensitivity and specificity in lipidomics.
Multi-omic data integration is challenging but necessary to uncover the mechanism(s) responsible for the lipid metabolism changes of a biological system after perturbation. A typical workflow of lipidomic analysis of biological samples. High mass accuracy MS Utilization of high mass resolution and mass accuracy instruments to sensitively acquire full MS spectra in the survey scan mode and to rapidly perform product ion scans step by step within an entire mass region of interest; multi-PIS or NLS extracted from the acquired data array of the product ion spectra to identify individual species and quantify identified species through the sum of the intensities of fragments of a molecular ion in comparison to that of internal standard; or datadependent acquistion to acquire product ion spectra for identification and well-resolved high mass accuracy full mass spectra for quantification 
